AGL 38.75 Increased By ▲ 0.05 (0.13%)
AIRLINK 137.10 Decreased By ▼ -0.78 (-0.57%)
BOP 5.37 Decreased By ▼ -0.06 (-1.1%)
CNERGY 3.87 Increased By ▲ 0.09 (2.38%)
DCL 8.09 Increased By ▲ 0.35 (4.52%)
DFML 45.74 Increased By ▲ 0.12 (0.26%)
DGKC 83.30 Increased By ▲ 2.80 (3.48%)
FCCL 30.27 Increased By ▲ 0.72 (2.44%)
FFBL 57.60 Increased By ▲ 1.80 (3.23%)
FFL 9.14 Increased By ▲ 0.05 (0.55%)
HUBC 106.85 Increased By ▲ 1.25 (1.18%)
HUMNL 14.30 Increased By ▲ 0.25 (1.78%)
KEL 4.68 Increased By ▲ 0.38 (8.84%)
KOSM 7.98 Decreased By ▼ -0.25 (-3.04%)
MLCF 38.93 Increased By ▲ 0.95 (2.5%)
NBP 67.60 Decreased By ▼ -1.63 (-2.35%)
OGDC 168.99 Increased By ▲ 1.99 (1.19%)
PAEL 25.38 Increased By ▲ 0.18 (0.71%)
PIBTL 5.94 Decreased By ▼ -0.84 (-12.39%)
PPL 131.00 Increased By ▲ 0.65 (0.5%)
PRL 23.76 No Change ▼ 0.00 (0%)
PTC 15.75 Increased By ▲ 0.05 (0.32%)
SEARL 64.75 Increased By ▲ 3.27 (5.32%)
TELE 7.40 Increased By ▲ 0.36 (5.11%)
TOMCL 36.09 Decreased By ▼ -0.01 (-0.03%)
TPLP 7.86 Increased By ▲ 0.05 (0.64%)
TREET 14.93 Decreased By ▼ -0.22 (-1.45%)
TRG 45.25 Increased By ▲ 0.36 (0.8%)
UNITY 25.83 Increased By ▲ 0.32 (1.25%)
WTL 1.29 Increased By ▲ 0.02 (1.57%)
BR100 9,347 Increased By 123.7 (1.34%)
BR30 28,113 Increased By 346.6 (1.25%)
KSE100 87,195 Increased By 728 (0.84%)
KSE30 27,397 Increased By 234 (0.86%)
Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Published April 9, 2021

BERLIN: The European Union will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine to cover the bloc's need for booster shots over the coming two years, German daily Die Welt reported on Friday.

The newspaper said that contracts would be signed for deliveries of 900 million doses, with further contracts creating an option for another 900 million doses to be bought. The planned purchases would also cover the 70-80 million children in the EU, who are not currently being vaccinated.

The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.

Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.

Comments

Comments are closed.